1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    















































































































    Decreased Diffusivity in the Caudate Nucleus of Presymptomatic Huntington Disease Gene Carriers: Which Explanation? | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBrain

  
      

  
      
Decreased Diffusivity in the Caudate Nucleus of Presymptomatic Huntington Disease Gene Carriers: Which Explanation?
  
    	
M.L. Mandelli, M. Savoiardo, L. Minati, C. Mariotti, D. Aquino, A. Erbetta, S. Genitrini, S. Di Donato, M.G. Bruzzone and M. Grisoli

  
    	
American Journal of Neuroradiology April 2010,  31 (4) 706-710; DOI: https://doi.org/10.3174/ajnr.A1891 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes: Huntington's Disease Collaborative Research Group. Cell 1993; 72: 971–83
    CrossRefPubMedWeb of Science
  2. 2.↵


    1. Aylward  EH, 
    2. Codori  A, 
    3. Rosenblatt  A, 
    4. et al
    . Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington's disease. Mov Disord 2000; 15: 552–60
    CrossRefPubMedWeb of Science
  3. 3.↵


    1. Aylward  EH, 
    2. Rosenblatt  A, 
    3. Field  K, 
    4. et al
    . Caudate volume as an outcome measure in clinical trials for Huntington's disease: a pilot study. Brain Res Bull 2003; 62: 137–41
    CrossRefPubMed
  4. 4.↵


    1. Aylward  EH
    . Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease. Brain Res Bull 2007; 72: 152–58. Epub 2006 Nov 2
    CrossRefPubMedWeb of Science
  5. 5.↵


    1. Aylward  EH, 
    2. Sparks  BF, 
    3. Field  BA, 
    4. et al
    . Onset and rate of striatal atrophy in preclinical Huntington disease. Neurology 2004; 63: 66–72
    CrossRefPubMed
  6. 6.↵


    1. Le Bihan  D, 
    2. Turner  R, 
    3. Douek  P, 
    4. et al
    . Diffusion MR imaging: clinical applications. AJR Am J Roentgenol 1992; 159: 591–99
    PubMedWeb of Science
  7. 7.↵


    1. Seppi  K, 
    2. Schocke  MF, 
    3. Mair  KJ, 
    4. et al
    . Diffusion-weighted imaging in Huntington's disease. Mov Disord 2006; 21: 1043–47
    CrossRefPubMedWeb of Science
  8. 8.↵


    1. Mascalchi  M, 
    2. Lolli  F, 
    3. Della  NR, 
    4. et al
    . Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology 2004; 232: 867–73
    CrossRefPubMedWeb of Science
  9. 9.↵


    1. Rosas  HD, 
    2. Tuch  DS, 
    3. Hevelone  ND, 
    4. et al
    . Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures. Mov Disord 2006; 21: 1317–25
    CrossRefPubMedWeb of Science
  10. 10.↵


    Guidelines for the molecular genetics predictive test in Huntington's disease: International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea. Neurology 1994; 44: 1533–36
    CrossRef
  11. 11.↵


    1. Langbehn  DR, 
    2. Brinkman  RR, 
    3. Falush  D, 
    4. et al
    . A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin Genet 2004; 65: 267–77
    CrossRefPubMedWeb of Science
  12. 12.↵


    Unified Huntington's Disease Rating Scale: reliability and consistency—Huntington Study Group. Mov Disord 1996; 11: 136–42
    CrossRefPubMedWeb of Science
  13. 13.↵


    1. Marder  K, 
    2. Zhao  H, 
    3. Myers  RH, 
    4. et al
    . Rate of functional decline in Huntington's disease: Huntington Study Group. Neurology 2000; 54: 452–58
    CrossRefPubMed
  14. 14.↵


    1. Alemán-Gómez  Y, 
    2. Melie-García  L, 
    3. Valdés-Hernandez  P
    . IBASPM: toolbox for automatic parcellation of brain structures. Presented at: 12th Annual Meeting of the Organization for Human Brain Mapping, Florence, Italy, June 11–15, 2006
  15. 15.↵


    1. Tzourio-Mazoyer  N, 
    2. Landeau  B, 
    3. Papathanassiou  D, 
    4. et al
    . Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 2002; 15: 273–89
    CrossRefPubMedWeb of Science
  16. 16.↵


    1. Looi  JC, 
    2. Lindberg  O, 
    3. Liberg  B, 
    4. et al
    . Volumetrics of the caudate nucleus: reliability and validity of a new manual tracing protocol. Psychiatry Res 2008; 163: 279–88
    CrossRefPubMedWeb of Science
  17. 17.↵


    1. Basser  PJ, 
    2. Mattiello  J, 
    3. LeBhian  D
    . Estimation of the self-diffusion tensor from the NMR spin echo. J Magn Reson B 1994; 103: 247–54
    CrossRefPubMedWeb of Science
  18. 18.↵


    1. Kassubek  J, 
    2. Juengling  FD, 
    3. Kioschies  T, 
    4. et al
    . Topography of cerebral atrophy in early Huntington's disease: a voxel based morphometric MRI study. J Neurol Neurosurg Psychiatry 2004; 75: 213–20
    Abstract/FREE Full Text
  19. 19.↵


    1. Douaud  G, 
    2. Gaura  V, 
    3. Ribeiro  MJ, 
    4. et al
    . Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 2006; 32: 1562–75
    CrossRefPubMedWeb of Science
  20. 20.↵


    1. Vonsattel  JP, 
    2. Myers  RH, 
    3. Stevens  TJ, 
    4. et al
    . Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol 1985; 44: 559–77
    CrossRefPubMedWeb of Science
  21. 21.↵


    1. Taylor-Robinson  SD, 
    2. Weeks  RA, 
    3. Bryant  DJ, 
    4. et al
    . Proton magnetic resonance spectroscopy in Huntington's disease: evidence in favour of the glutamate excitotoxic theory. Mov Disord 1996; 1: 167–73
  22. 22.↵


    1. Ciarmiello  A, 
    2. Cannella  M, 
    3. Lastoria  S, 
    4. et al
    . Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J Nucl Med 2006; 47: 215–22
    Abstract/FREE Full Text
  23. 23.↵


    1. Snook  L, 
    2. Plewes  C, 
    3. Beaulieu  C
    . Voxel-based versus region of interest analysis in diffusion tensor imaging of neurodevelopment. Neuroimage 2007; 34: 243–52
    CrossRefPubMedWeb of Science
  24. 24.↵


    1. Seppi  K, 
    2. Scherfler  C, 
    3. Nocker  M, 
    4. et al
    . Diffusion weighted imaging in presymptomatic and early Huntington's disease. Mov Dis 2008; 23: 77
  25. 25.↵


    1. Gomez-Tortosa  E, 
    2. MacDonald  ME, 
    3. Friend  JC, 
    4. et al
    . Quantitative neuropathological changes in presymptomatic Huntington's Disease. Ann Neurol 2001; 49: 29–34
    CrossRefPubMedWeb of Science
  26. 26.↵


    1. Myers  RH, 
    2. Vonsattel  JP, 
    3. Paskevich  PS, 
    4. et al
    . Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol 1991; 50: 729–42
    CrossRefPubMedWeb of Science
  27. 27.↵


    1. Beaulieu  C
    . The basis of anisotropic water diffusion in the nervous system: a technical review. NMR Biomed 2002; 15: 435–55
    CrossRefPubMedWeb of Science
  28. 28.↵


    1. Minati  L, 
    2. Aquino  D, 
    3. Rampoldi  S, 
    4. et al
    . Biexponential and diffusional kurtosis imaging, and generalised diffusion-tensor imaging (GDTI) with rank-4 tensors: a study in a group of healthy subjects. MAGMA 2007; 20: 241–53
    CrossRefPubMed
  29. 29.↵


    1. Sener  RN
    . Echo-planar and gradient-echo diffusion MRI of normal brain iron in the globus pallidus. Clin Imaging 2002; 6: 371–74
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Decreased Diffusivity in the Caudate Nucleus of Presymptomatic Huntington Disease Gene Carriers: Which Explanation?
  
    	
M.L. Mandelli, M. Savoiardo, L. Minati, C. Mariotti, D. Aquino, A. Erbetta, S. Genitrini, S. Di Donato, M.G. Bruzzone, M. Grisoli

  
    	
American Journal of Neuroradiology Apr 2010, 31 (4) 706-710; DOI: 10.3174/ajnr.A1891 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement